Home Compliance Teva and Glenmark Settle Drug Price-Fixing Allegations at an Expense of More... ComplianceNews Teva and Glenmark Settle Drug Price-Fixing Allegations at an Expense of More Than a Quarter-Billion Dollars August 23, 2023 18 Share FacebookLinkedinTwitter Aleksandra Gigowska | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance Whistleblower Network News: DOJ Must Listen to the Whistleblower Community in Developing Whistleblower Program Compliance Staffing Company Settles Cybersecurity FCA Violation Case for $2.7M Compliance DOJ’s First Intervention in Cybersecurity FCA Qui Tam Case Signals Continued Cyber Enforcement